115 related articles for article (PubMed ID: 10221109)
1. [Treatment of Helicobacter pylori infections].
van der Hulst RW; van 't Hoff BW; van der Ende A; Tytgat GN
Ned Tijdschr Geneeskd; 1999 Feb; 143(8):395-400. PubMed ID: 10221109
[TBL] [Abstract][Full Text] [Related]
2. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
Chu KM; Kwok KF; Law SY; Wong J
Hepatogastroenterology; 2000; 47(36):1624-6. PubMed ID: 11149018
[TBL] [Abstract][Full Text] [Related]
3. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
4. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
5. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
6. Eradication of Helicobacter pylori.
O'Connor HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S113-9. PubMed ID: 7735927
[TBL] [Abstract][Full Text] [Related]
7. Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Uthaisaengsook W
J Med Assoc Thai; 2003 Jul; 86(7):599-602. PubMed ID: 12948252
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
Chuang CH; Sheu BS; Kao AW; Cheng HC; Huang AH; Yang HB; Wu JJ
Hepatogastroenterology; 2007; 54(73):320-4. PubMed ID: 17419283
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
Fischbach LA; van Zanten S; Dickason J
Aliment Pharmacol Ther; 2004 Nov; 20(10):1071-82. PubMed ID: 15569109
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
12. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study.
Palmas F; Pellicano R; Massimetti E; Berrutti M; Fagoonee S; Rizzetto M
Panminerva Med; 2002 Jun; 44(2):145-7. PubMed ID: 12032434
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Helicobacter pylori infection.
Miehlke S; Bayerdörffer E; Graham DY
Semin Gastrointest Dis; 2001 Jul; 12(3):167-79. PubMed ID: 11478749
[TBL] [Abstract][Full Text] [Related]
16. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
18. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
19. [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
Sainz R; Borda F; Domínguez E; Gisbert JP
Rev Esp Enferm Dig; 1999 Nov; 91(11):777-84. PubMed ID: 10601771
[TBL] [Abstract][Full Text] [Related]
20. How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy.
Vaira D; Ricci C; Lanzini A; Perna F; Romano A; Corinaldesi R
Dig Dis; 2007; 25(3):203-5. PubMed ID: 17827940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
